ELAPRASE 2 mg/ml, concentrate for solution for infusion bottle, 3 ml, CIP 3400930236536
Active ingredients: Idursulfase
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 3 ml, CIP 3400930236536intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELAPRASE 2 mg/ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 3 ml
- Marketing authorisation holder
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
63288174CIP73023653CIP133400930236536Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IDURSULFASEsolution | 2 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.